SkylineDx

Skyline

SkylineDx develops molecular diagnostic tests for oncology and inflammatory diseases to assist healthcare providers and patients with personalised treatment decisions.

Delphi Diagnostics

This company develops genomic tests for breast cancer to assist clinicians and patients in personalising treatment decisions and predicting long-term survival outcomes.

Persona-Dx

The company develops artificial intelligence biomarker tests for tissue and blood samples to help oncologists personalise cancer diagnosis and treatment for metastatic patients.

Astron Health

This company develops a precision oncology platform that provides molecular data analysis and personalised treatment reports for cancer patients and their clinicians.

Veracyte

This company develops genomic tests and diagnostic tools to help clinicians and patients make informed treatment decisions for various types of cancer.

Molecular Stethoscope

This company develops blood-based liquid biopsy tests that analyse cell-free messenger RNA to help clinicians and researchers detect and monitor diseases.

MultiplexDX

This company develops molecular diagnostic tests and reagents for oncologists and research institutions to improve cancer profiling and infectious disease detection.

Oxford Cancer Biomarkers

This company develops and commercialises precision diagnostic tests and digital pathology tools to help clinicians personalise cancer treatment and assess patient toxicity risks.